Status:
COMPLETED
Effect of Replacement Volume of Haemodiafiltration and AST-120 on Toxins, Oxidative Stress and MicroInflammation
Lead Sponsor:
Tungs' Taichung Metroharbour Hospital
Conditions:
Loss of Solute Clearance
Eligibility:
All Genders
20-80 years
Phase:
PHASE4
Brief Summary
Accumulating evidence suggested that increased oxidative stress (OxSt) as well as inflammation are risk factors for cardiovascular events in hemodialysis patients. The incremental effect of online hae...
Detailed Description
Background High convection volume OL-HDF techniques constitute progress towards renal replacement therapy which is most similar to the native kidney. These techniques offer a higher clearance of urem...
Eligibility Criteria
Inclusion
- Thrice a week for more then
- Receiving HDF patients who had been treated for \> 3 months
- Non-smoking
- Informed Consent
- No significant change of medication
Exclusion
- Malignancy
- Active infection
- Congestive heart failure (CHF)
- History of Gastrointestinal Disease(Active peptic ulcer, severe constipation or severe GI dysmotility)
Key Trial Info
Start Date :
January 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2013
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01458652
Start Date
January 1 2011
End Date
October 1 2013
Last Update
May 9 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
PS Lim
Taichung, Taiwan, 435